CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells

被引:49
作者
Johnson-Léger, C [1 ]
Christensen, J [1 ]
Klaus, GGB [1 ]
机构
[1] Natl Inst Med Res, Div Cellular Immunol, London NW7 1AA, England
关键词
CD40; ligand; T cell-B cell collaboration;
D O I
10.1093/intimm/10.8.1083
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ligand for CD40 (CD40L) is a protein which is expressed on CD4 T cells following their activation: CD40-CD40L interactions are absolutely required for the induction of T cell-dependent antibody responses, yet little is known about the mechanisms whereby CD40L(+) primary T cells activate naive B cells, since the protein is only transiently expressed and is rapidly down-regulated following T cell-B cell contact. We show here, using a variety of assays, that co-stimulation of primary murine T cells via CD3 and CD28 stabilizes the expression of the CD40L protein. Firstly, T cells stimulated in this manner express higher levels of CD40L when activated in the presence of B cells, compared to CD3-activated T cells. Secondly, the CD40L expressed on CD28-co-stimulated T cells is more resistant to B cell-induced down-regulation. Finally, CD3/CD28-preactivated, rested T cells re-express higher levels of CD40L more rapidly following re-stimulation via CD3 than T cells preactivated via CD3 atone. CD3/CD28-preactivated T cells, but not CD3-activated cells, are competent to induce DNA synthesis in naive B cells, and this requires re-stimulation via CD3 and prolonged ligation of CD40, These data therefore reinforce the concept that naive T cells need to be activated initially by cognate interaction with B7-bearing antigen-presenting cells (such as dendritic cells), before becoming competent helper effector cells capable of driving B cells into proliferation via a CD40-dependent pathway.
引用
收藏
页码:1083 / 1091
页数:9
相关论文
共 41 条
  • [1] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [2] CD40 LIGAND AND ITS ROLE IN X-LINKED HYPER-IGM SYNDROME
    CALLARD, RE
    ARMITAGE, RJ
    FANSLOW, WC
    SPRIGGS, MK
    [J]. IMMUNOLOGY TODAY, 1993, 14 (11): : 559 - 564
  • [3] CASTLE BE, 1993, J IMMUNOL, V151, P1777
  • [4] HOW B-CELLS AND T-CELLS TALK TO EACH OTHER
    CLARK, EA
    LEDBETTER, JA
    [J]. NATURE, 1994, 367 (6462) : 425 - 428
  • [5] CD40-CD40 ligand interaction in autoimmune disease
    Datta, SK
    Kalled, SL
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (10): : 1735 - 1745
  • [6] LIGATION OF B7 WITH CD28 CTLA-4 ON T-CELLS RESULTS IN CD40 LIGAND EXPRESSION, INTERLEUKIN-4 SECRETION AND EFFICIENT HELP FOR ANTIBODY-PRODUCTION BY B-CELLS
    DEBOER, M
    KASRAN, A
    KWEKKEBOOM, J
    WALTER, H
    VANDENBERGHE, P
    CEUPPENS, JL
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) : 3120 - 3125
  • [7] REGULATION OF GROWTH AND PROLIFERATION IN B-CELL SUB-POPULATIONS
    DEFRANCO, AL
    KUNG, JT
    PAUL, WE
    [J]. IMMUNOLOGICAL REVIEWS, 1982, 64 : 161 - 182
  • [8] DING L, 1995, J IMMUNOL, V155, P5124
  • [9] Ferguson SE, 1996, J IMMUNOL, V156, P4576
  • [10] IN-VIVO CD40-GP39 INTERACTIONS ARE ESSENTIAL FOR THYMUS-DEPENDENT HUMORAL IMMUNITY .2. PROLONGED SUPPRESSION OF THE HUMORAL IMMUNE-RESPONSE BY AN ANTIBODY TO THE LIGAND FOR CD40, GP39
    FOY, TM
    SHEPHERD, DM
    DURIE, FH
    ARUFFO, A
    LEDBETTER, JA
    NOELLE, RJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1567 - 1575